Skip to main content
Torrent Pharmaceuticals Ltd. logo

Torrent Pharmaceuticals Ltd. — Investor Relations & Filings

Ticker · TORNTPHARM ISIN · INE685A01028 LEI · 335800NA6HK275RIJE13 BSE.NS Manufacturing
Open in API
Filings indexed 1,760 across all filing types
Latest filing 2024-10-24 Regulatory Filings
Country IN India
Listing BSE.NS TORNTPHARM

About Torrent Pharmaceuticals Ltd.

https://www.torrentpharma.com

Torrent Pharmaceuticals Ltd. is a research-driven organization focused on the development, manufacturing, and marketing of generic formulations. The company holds a significant position in therapeutic areas such as cardiovascular, central nervous system, gastrointestinal, diabetology, and anti-infective treatments. It has strategically expanded its portfolio into dermatology, nephrology, and pain management through targeted acquisitions. The firm operates across multiple international markets, supported by advanced research and development centers and manufacturing facilities that adhere to global regulatory standards. Its core operations prioritize chronic therapy leadership and the provision of high-quality healthcare solutions through a robust pipeline of generic and value-added medicines.

Recent filings

Filing Released Lang Actions
Intimation of Loss of Share Certificates
Regulatory Filings
2024-10-24 English
Loss of Share Certificates
Regulatory Filings
2024-10-21 English
Intimation of Loss of Share Certificates
Regulatory Filings
2024-10-21 English
General Updates
Regulatory Filings Classification · 95% confidence The document is a disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It informs about a demand notice issued by the National Pharmaceutical Pricing Authority regarding a penalty. The document is a regulatory announcement informing the stock exchanges and investors about a regulatory action but does not contain financial statements, detailed financial analysis, or management discussion. It is a short communication primarily for compliance and disclosure purposes. The document length is 2595 characters, which is short and does not contain a full report or detailed financial data. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance disclosures that do not fit other specific categories.
2024-10-18 English
Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings Classification · 95% confidence The document is a disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, informing about a demand notice issued by the National Pharmaceutical Pricing Authority. It is a regulatory announcement about a legal/administrative action and its impact on the company. The document is short (2595 characters) and does not contain financial statements or detailed financial data. It is not a report but a regulatory disclosure. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-10-18 English
Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Legal Proceedings Report Classification · 95% confidence The document is a disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, informing about a demand notice issued by the National Pharmaceutical Pricing Authority. It details the nature of the demand notice, the authority issuing it, the date, and the impact on the company. The document is a regulatory announcement about a legal/regulatory action but does not contain financial statements or detailed financial analysis. It is not an annual report, earnings release, or any financial report. It is also not a report publication announcement or certification. The content fits best under Legal Proceedings Report (LTR) as it updates on a regulatory action involving the company.
2024-10-15 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.